Enabling Direct Therapeutic Access Beyond the Blood-Brain Barrier BALTIMORE, /PRNewswire/ -- CraniUS Therapeutics LLC, a privately held neurotechnology company, today announced it has raised $20 ...

An interdisciplinary multi-center research team led by the LKS Faculty of Medicine (HKUMed) and Faculty of Dentistry at the ...

Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...

A team of Canadian scientists has uncovered a new way to slow the growth of glioblastoma, the most aggressive and currently ...

The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient recruitment to ...

The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe’s most intricate and dynamic structures. However, the complexity and sensitivity of the brain can ...

Modern cancer therapies have resulted in higher survival rates for victims of this dread disease, in many cases. However, their generic mode of delivery and action is associated with greater adverse ...

Targeted drug delivery is a powerful and promising area of medicine. Therapies that pinpoint the exact areas of the body where they're needed—and nowhere they're not—can reduce the medicine dosage and ...

An international clinical study led by the Medical University of Vienna shows that the drug patritumab deruxtecan (HER3-DXd) can have a promising effect in patients with active brain metastases of ...

A man with the deadliest form of brain cancer has no signs of the disease after taking an experimental drug. Ben Trotman was 40 when he was diagnosed in 2022 with glioblastoma, the most aggressive ...